PL373808A1 - Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids - Google Patents

Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids

Info

Publication number
PL373808A1
PL373808A1 PL03373808A PL37380803A PL373808A1 PL 373808 A1 PL373808 A1 PL 373808A1 PL 03373808 A PL03373808 A PL 03373808A PL 37380803 A PL37380803 A PL 37380803A PL 373808 A1 PL373808 A1 PL 373808A1
Authority
PL
Poland
Prior art keywords
alpha
hydroxysteroids
substituted
production
microbiological method
Prior art date
Application number
PL03373808A
Other languages
English (en)
Polish (pl)
Inventor
Ludwig Zorn
Rolf Bohlmann
Norbert Gallus
Hermann Künzer
Hans-Peter Muhn
Reinhard Nubbemeyer
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL373808A1 publication Critical patent/PL373808A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL03373808A 2002-07-24 2003-07-24 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids PL373808A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
PL373808A1 true PL373808A1 (en) 2005-09-19

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373808A PL373808A1 (en) 2002-07-24 2003-07-24 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids

Country Status (20)

Country Link
EP (1) EP1523568A2 (ru)
JP (1) JP4417838B2 (ru)
KR (1) KR101041328B1 (ru)
CN (1) CN100339486C (ru)
BR (1) BR0313210A (ru)
CA (1) CA2492079C (ru)
CO (1) CO5690563A2 (ru)
CR (1) CR7672A (ru)
EA (2) EA008147B1 (ru)
EC (1) ECSP055630A (ru)
HK (1) HK1081999A1 (ru)
HR (1) HRP20050172A2 (ru)
IL (1) IL166358A0 (ru)
MX (1) MXPA05001024A (ru)
NO (1) NO20050980L (ru)
NZ (2) NZ537871A (ru)
PH (1) PH12005500143B1 (ru)
PL (1) PL373808A1 (ru)
RS (1) RS51855B (ru)
WO (1) WO2004011663A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049672A1 (ja) * 2005-10-27 2007-05-03 Taiho Pharmaceutical Co., Ltd. ステロイド化合物の製造法
CN103834712B (zh) * 2012-11-26 2016-03-30 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因
PL442098A1 (pl) * 2022-08-26 2024-03-04 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania 11α-hydroksy-19-nortestosteronu

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE496261A (ru) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) * 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) * 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) * 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167381A3 (en) * 1995-12-11 2004-09-29 G.D. Searle & Co. Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein
ES2175175T3 (es) 1995-12-12 2002-11-16 Akzo Nobel Nv Un metodo microbiano para la 11alfa-hidroxilacion de esteroides.
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
ES2282230T3 (es) 2000-02-15 2007-10-16 Bayer Schering Pharma Aktiengesellschaft Formulacion anticonceptiva masculina que comprende noretisterona u undecanoato de testosterona.
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
ATE382355T1 (de) * 2002-07-25 2008-01-15 Bayer Schering Pharma Ag Zusammensetzung, enthaltend ein androgenes 11-b- halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung

Also Published As

Publication number Publication date
IL166358A0 (en) 2006-01-16
CR7672A (es) 2006-05-29
EA200601030A1 (ru) 2006-10-27
CN1671858A (zh) 2005-09-21
CN100339486C (zh) 2007-09-26
EA200500224A1 (ru) 2005-08-25
PH12005500143B1 (en) 2011-03-25
MX260952B (ru) 2008-10-01
KR101041328B1 (ko) 2011-06-14
KR20050026507A (ko) 2005-03-15
EA010572B1 (ru) 2008-10-30
EA008147B1 (ru) 2007-04-27
NZ537871A (en) 2006-10-27
WO2004011663A3 (de) 2004-07-15
NZ549529A (en) 2008-04-30
CA2492079A1 (en) 2004-02-05
HK1081999A1 (en) 2006-05-26
JP2006503813A (ja) 2006-02-02
NO20050980L (no) 2005-02-23
EP1523568A2 (de) 2005-04-20
CA2492079C (en) 2012-01-10
CO5690563A2 (es) 2006-10-31
RS51855B (sr) 2012-02-29
ECSP055630A (es) 2005-04-18
WO2004011663A9 (de) 2004-05-06
MXPA05001024A (es) 2005-05-16
JP4417838B2 (ja) 2010-02-17
HRP20050172A2 (en) 2005-04-30
RS20050045A (en) 2007-06-04
BR0313210A (pt) 2005-06-28
AU2003281677A1 (en) 2004-02-16
WO2004011663A2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
ZA200605864B (en) Method for the production of methionine
AU2003219592A1 (en) Chiral intermediate and process for the production thereof
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
HK1081999A1 (en) Microbiological method for the production of 7 alpha-substituted 11 alpha-hydrox-ysteroids
AU2003293895A1 (en) Method for the production of isocyanates
IL158400A0 (en) Process for the production of citalopram
AU2003293477A1 (en) Method for the production of polycarbonates
GB0216311D0 (en) An improved process for the production of substituted thioxanthones
IL166631A0 (en) Process for the production of bisphenol-a
PL375101A1 (en) Process for the production of 3-methylthiopropanal
HUP0401111A3 (en) Microbiological method for producing amides
AU2003293272A1 (en) Method for the production of bioprostheses
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
AU2003258622A1 (en) Method for the production of $g(b)-carotinoids
IL162770A0 (en) Process for the preparation methylsteroids of 7
AU2003292209A8 (en) Method for the production of optically active dihydropyrones
AU2003267541A1 (en) Method for the production of substituted trifluoroethylenes
AU2003281677B2 (en) Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
IL158119A0 (en) Method for the production of delta1-pyrrolines
AU2003264134A1 (en) Sarcolysyl derivatives and method for the production thereof
EP1553073A4 (en) PROCESS FOR PREPARING 1,2,4-BUTANTRIOL
AU2003245879A1 (en) Method for the production of substituted trifluoroetylenes
IL164437A0 (en) Method for the production of 2,4,5-trimethylphenylacetic acid
AU2003283245A8 (en) Method for the production of 1,6-hexanediol
AU2003233239A1 (en) Method for the production of polymethylenepolysulfides

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)